United States Research on Active Pharmaceutical Ingredients For Manufacture Of Drugs And That Have Pharmacological Effects, to Grow at a CAGR of 7.01% Period 2016-2019
"Active Pharmaceutical Ingredients (API) Market in the US 2016-2019" The Report covers current Market Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect.
Active pharmaceutical ingredients (API) are active substances that are used in the manufacture of drugs and that have pharmacological effects. They provide health benefits and play a vital role in disease diagnosis, prevention, and treatment. API may be synthesized either chemically or through biotechnological methods. They are used in a wide range of therapeutic areas such as oncology and for treatment of conditions such as respiratory disorders and rheumatoid arthritis.
Get Sample Report With TOC @ https://goo.gl/dHZFW8
TechNavio's analysts forecast the API market in the US to grow at a CAGR of 7.01 percent over the period 2016-2019.
- Covered in this Report
The report covers the present scenario and the growth prospects of the API market in the US for the period 2016-2019. To calculate the market size, the report considers the revenue generated from the sales of API by vendors in the market. It provides the vendor landscape and a corresponding detailed analysis of the top vendors in the market. The market segmentation is carried out on the basis of: type of production process (synthetic production process and biotechnology-based production process), type of product (conventional API and high-potency API), and type of players (captive and merchant).
The report discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.
TechNavio's report, the API Market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts.
- Key Vendors
Teva Pharmaceutical Industries
- Other Prominent Vendors
Dr. Reddy's Laboratories
Sun Pharmaceutical Industries
- Market Driver
Strong Preference for Generic Drugs
For a full, detailed list, view our report
- Market Challenge
Decrease in R&D Spending
For a full, detailed list, view our report
- Market Trend
Strong Focus on High-potency API
For a full, detailed list, view our report
- Key Questions Answered in this Report
What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Researchmoz Global Pvt. Ltd.
90 State Street,
Albany, NY 12207,
Tel: 866-997-4948 (Us-Canada Toll Free),
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Research on Active Pharmaceutical Ingredients For Manufacture Of Drugs And That Have Pharmacological Effects, to Grow at a CAGR of 7.01% Period 2016-2019 here
News-ID: 408395 • Views: 636
More Releases from Active Pharmaceutical Ingredients
Global active pharmaceutical ingredients Market Report 2019 Companies included E …
#7th Edition active pharmaceutical ingredients market report recently has been published by market reports company. It features comprehensive market outlook based on historic data from 2013 to 2018 and estimated market trends during the forecast period from 2018 to 2026. To access complete insights of global active pharmaceutical ingredients market report: email@example.com The active pharmaceutical ingredients market delivers a wide array of primary and secondary data with respect to regional and
Active Pharmaceutical Ingredients to 2022 : Teva Pharmaceutical Industries, Camb …
Researchmoz added Most up-to-date research on "Active Pharmaceutical Ingredients: Global Markets to 2022" to its huge collection of research reports. Report Scope This report (Active Pharmaceutical Ingredients: Global Markets to 2022) covers an overview of the pharmaceutical industry landscape and active pharmaceutical ingredients (API), along with the current trends and dynamics shaping the API market landscape. API sourcing trends and regulatory guidelines that impact the procurement of API are studied here. The
Global Active Pharmaceutical Ingredients Industry Key Trends, Size, Growth, Shar …
Researchmoz added Most up-to-date research on "Global Active Pharmaceutical Ingredients Industry 2016, Trends and Forecast Report" to its huge collection of research reports. 2016 Global Active Pharmaceutical Ingredients Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Active Pharmaceutical Ingredients industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China). The report
US Active Pharmaceutical Ingredients (API) Market Size, Shares, Growth, Opportun …
Albany, NY, Dec 14: Active pharmaceutical ingredients (API) are active substances that are used in the manufacture of drugs and that have pharmacological effects. They provide health benefits and play a vital role in disease diagnosis, prevention, and treatment. API may be synthesized either chemically or through biotechnological methods. They are used in a wide range of therapeutic areas such as oncology and for treatment of conditions such as respiratory
More Releases for API
Terminating Twitter API Integrations
Thexyz Inc, the leading private email service that protects people and their data announces that a Twitter authentication apps developed by Thexyz will be discontinued and no longer supported. Thexyz focuses on security, privacy, freedom, and an open internet that respects the rights of individuals. It is a goal to work with organizations that share these values and discontinue support for services that do not. Thexyz has developed applications
Tagraxofusp - API Insight, 2018
Tagraxofusp, sold under the brand name of Elzonris, is an Interleukin 3 (IL-3) conjugated truncated diphtheria toxin. It is composed of catalytic and translocation domains of diphtheria toxin fused via Met-His linker to a full-length human IL-3. Download the sample report @ https://www.pharmaproff.com/request-sample/1168 Tagraxofusp was developed by Stemline Therapeutics Inc. and was approved in December 2018, as the first therapy for blastic plasmacytoid dendritic cell neoplasm. This drug achieved approval after
Cabozantinib- API Insight, 2018
Cabozantinib, sold under the brand name of Cabometyx and Cometriq, is used for the treatment of medullary thyroid cancer and a second line treatment for renal cell carcinoma. It is a small molecule inhibitor of the tyrosine kinases c-Met and VEGFR2, and also inhibits AXL and RET. Download the sample report @ https://www.pharmaproff.com/request-sample/1164 Discovered and developed by Exelixis Inc., its side-effects include increased liver enzymes, diarrhea, low calcium, mouth sores, decreased
Tyk API Management v2.3
After months working-out in the gym, the new version of Tyk is ready to flex its muscles. Tyk v2.3 is twice as fast, leaner, more extendable and is still available for FREE! London, United Kingdom 8th December, 2016. Tyk Technologies is pleased to announce the v2.3 release of Tyk, the popular open-source API Management platform. Tyk v2.3 builds upon the success of previous releases. The feedback and contributions from Tyk’s thriving open source community, as well as enterprise clients, drove
Telecom API Helps Application Developers to Integrate Various API Services
Telecom API market represents an overall Application Programming Interface (API) services provided by telecom carriers, service providers and aggregators to application developers in order to create mobile applications. Telecom API helps application developers to integrate various services such as payment, voice, SMS and WebRTC into their mobile application. This helps application developers to enhance their customer experience and market their mobile applications among end-users. Telecom API provides many benefits to
Biotech API Surging Worldwide
According to a new research report by RNCOS, entitled “Global Biotech API Market Analysis”, geographies across the world are showing insurgent growth in the biotech API Industry. The US occupied more than half of the share in the global market in 2011, and is the largest producer of biotech APIs. Western European countries occupy around 15% share globally among which, the UK is the largest producer of biotechnology-based APIs. The